| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2016 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 2,997 | $5.52 | $16,543.44 | -1.3% | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,162 | $72.10 | $300,073.08 | - | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,873 | $70.40 | $272,643.66 | - | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,553 | $72.54 | $257,740.75 | - | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,000 | $71.77 | $287,096.55 | - | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,500 | $70.79 | $247,768.00 | - | |
| Feb 24, 2016 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 10,000 | $47.56 | $475,560.00 | -15.5% | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,500 | $71.32 | $320,918.50 | - | |
| Feb 24, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 800 | $72.89 | $58,308.50 | - | |
| Feb 24, 2016 | WST West Pharmaceutical Services Inc | Lennartz Heino | President Europe | Sell | 19,658 | $59.45 | $1,168,673.51 | -31.0% | |
| Feb 24, 2016 | WST West Pharmaceutical Services Inc | Bedwell Warwick | President, Pharma Pkgs Systems | Sell | 7,296 | $59.04 | $430,725.72 | -8.6% | |
| Feb 24, 2016 | PMDI Psychemedics Corp | Connick Harry F Sr | Director | Buy | 2,000 | $12.36 | $24,726.00 | +1.3% | |
| Feb 23, 2016 | CRL Charles River Laboratories International, Inc. | Milne George M Jr59 | Director | Sell | 10,440 | $73.02 | $762,318.60 | -2.8% | |
| Feb 23, 2016 | WST West Pharmaceutical Services Inc | Johnson Paula A | Director | Sell | 7,800 | $59.39 | $463,268.52 | -16.6% | |
| Feb 23, 2016 | CRL Charles River Laboratories International, Inc. | Chubb Stephen D | Director | Sell | 4,065 | $72.87 | $296,216.23 | -9.3% | |
| Feb 23, 2016 | WST West Pharmaceutical Services Inc | Zenner Patrick J | Director | Sell | 12,800 | $59.39 | $760,200.96 | -20.9% | |
| Feb 23, 2016 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 6,866 | $6.39 | $43,873.74 | -1.1% | |
| Feb 23, 2016 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 2,556 | $6.39 | $16,332.84 | -1.0% | |
| Feb 23, 2016 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 2,411 | $6.39 | $15,406.29 | -1.1% | |
| Feb 22, 2016 | MTD Mettler Toledo International Inc/ | Maerki Hans Ulrich | Director | Sell | 3,000 | $325.03 | $975,090.00 | -30.9% | |
| Feb 22, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,831 | $73.12 | $718,829.70 | - | |
| Feb 22, 2016 | MTD Mettler Toledo International Inc/ | Milne George M Jr59 | Director | Sell | 2,600 | $323.37 | $840,762.00 | -21.4% | |
| Feb 22, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,210 | $73.37 | $675,739.59 | - | |
| Feb 22, 2016 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 2,738 | $74.09 | $202,847.06 | - | |
| Feb 22, 2016 | WST West Pharmaceutical Services Inc | Bedwell Warwick | President, Pharma Pkgs Systems | Sell | 16,042 | $59.52 | $954,790.96 | -17.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.